Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Additional Effect of a Life Style Program on Antihypertensive Treatment With Telmisartan

NCT01108796 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01108796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01108796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Additional Effect of a Life Style Program on Antihypertensive Treatment With Telmisartan
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
September 30, 2008
Completion date
September 30, 2009
Enrollment
1,856 (actual)
Sites
182

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension